• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大亨廷顿舞蹈症患者及其照护者的疾病负担。

Disease Burden of Huntington's Disease (HD) on People Living with HD and Care Partners in Canada.

机构信息

Medlior Health Outcomes Research Ltd., Calgary, AB, Canada.

Hoffmann-La Roche Ltd., Mississauga, ON, Canada.

出版信息

J Huntingtons Dis. 2022;11(2):179-193. doi: 10.3233/JHD-210505.

DOI:10.3233/JHD-210505
PMID:35342095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9277690/
Abstract

BACKGROUND

Huntington's disease (HD) has been shown to reduce health-related quality of life (HRQoL) and affect healthcare resource utilization (HRU) among patients and care partners internationally but has not been studied specifically in the Canadian context.

OBJECTIVE

To characterize the burden of HD on individuals with HD and care partners of individuals with HD in Canada.

METHODS

An online survey was distributed (September 14-November 23, 2020) through patient organizations to collect data on demographic and clinical characteristics, as well as: HRQoL, measured using the 36-Item Short-Form Health Survey (SF-36v1); HRU, measured using the Client Service Receipt Inventory (CSRI); and care partner burden, measured using the Caregiver Strain Index (CSI) and Huntington's Disease Quality of Life Battery for Carers (HDQoL-C). Descriptive statistics were used to report data and compare subgroups.

RESULTS

A total of 62 adult individuals with HD (or their proxies) and 48 care partners met defined eligibility criteria. The mean [standard deviation] age was 51.2 [13.8] and 58.1 [13.9] years for individuals with HD and care partner respondents, respectively. For individuals with HD, the greatest HRQoL burden (i.e., lowest score) was for the SF-36v1 Role -Physical scale (46.8 [42.9]). HRU was higher for some services (e.g., general practitioner visits) for respondents who had experienced motor onset transition. Among care partners, 55.3% experienced high strain, as indicated by the CSI. The HDQoL-C showed the greatest HRQoL burden in feelings about life (45.1 [17.9]).

CONCLUSION

This study quantified the substantial burden on individuals with HD and care partners in Canada, addressing a critical knowledge gap that can affect the availability of and access to healthcare services.

摘要

背景

亨廷顿病(HD)已被证明会降低国际上患者和患者照护者的健康相关生活质量(HRQoL)并影响其医疗资源的利用(HRU),但在加拿大特定环境下尚未进行专门研究。

目的

描述加拿大 HD 患者及其照护者的 HD 负担。

方法

通过患者组织在线分发(2020 年 9 月 14 日至 11 月 23 日)调查问卷,收集人口统计学和临床特征以及以下方面的数据:使用 36 项简短健康调查(SF-36v1)测量的 HRQoL;使用客户服务收据清单(CSRI)测量的 HRU;使用 caregiver 压力指数(CSI)和亨廷顿病照护者生活质量量表(HDQoL-C)测量的 care partner 负担。使用描述性统计数据报告数据并比较亚组。

结果

共有 62 名符合条件的 HD 成年患者(或其代理人)及其 48 名照护者参与了研究。HD 患者和照护者受访者的平均[标准差]年龄分别为 51.2[13.8]和 58.1[13.9]岁。对于 HD 患者,SF-36v1 角色-身体量表(46.8[42.9])的 HRQoL 负担最大(即得分最低)。对于经历过运动起始转换的受访者,一些服务(例如全科医生就诊)的 HRU 更高。在照护者中,55.3%的人存在高压力,CSI 显示出这一结果。HDQoL-C 在生活感受方面显示出最大的 HRQoL 负担(45.1[17.9])。

结论

本研究量化了加拿大 HD 患者及其照护者的巨大负担,填补了可能影响医疗保健服务可及性和可获得性的重要知识空白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b2/9277690/e2f2286503fa/jhd-11-jhd210505-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b2/9277690/e2f2286503fa/jhd-11-jhd210505-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b2/9277690/e2f2286503fa/jhd-11-jhd210505-g001.jpg

相似文献

1
Disease Burden of Huntington's Disease (HD) on People Living with HD and Care Partners in Canada.加拿大亨廷顿舞蹈症患者及其照护者的疾病负担。
J Huntingtons Dis. 2022;11(2):179-193. doi: 10.3233/JHD-210505.
2
Health related quality of life, service utilization and costs for patients with Huntington's disease in Norway.挪威亨廷顿病患者的健康相关生活质量、服务利用和费用。
BMC Health Serv Res. 2022 Dec 14;22(1):1527. doi: 10.1186/s12913-022-08881-8.
3
Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claims‑based retrospective cohort study.迟发性与成年发病型亨廷顿病患者的医疗资源利用和成本:一项基于理赔的回顾性队列研究。
J Med Econ. 2023 Jan-Dec;26(1):862-870. doi: 10.1080/13696998.2023.2228166.
4
Health-related quality of life in Huntington's disease patients: a comparison of proxy assessment and patient self-rating using the disease-specific Huntington's disease health-related quality of life questionnaire (HDQoL).亨廷顿病患者的健康相关生活质量:使用特定于疾病的亨廷顿病健康相关生活质量问卷(HDQoL)对代理评估和患者自评进行比较。
J Neurol. 2012 Sep;259(9):1793-800. doi: 10.1007/s00415-011-6405-2. Epub 2012 Mar 6.
5
Informal care in Huntington's disease: Assessment of objective-subjective burden and its associated risk and protective factors.亨廷顿病中的非正规护理:客观-主观负担及其相关风险和保护因素的评估。
Ann Phys Rehabil Med. 2023 May;66(4):101703. doi: 10.1016/j.rehab.2022.101703. Epub 2022 Dec 2.
6
Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN).亨廷顿病的健康状态效用值(QALY 权重):来自欧洲亨廷顿病网络(EHDN)的数据分析。
Eur J Health Econ. 2019 Dec;20(9):1335-1347. doi: 10.1007/s10198-019-01092-9. Epub 2019 Aug 13.
7
A psychometric comparison of two carer quality of life questionnaires in Huntington's disease: implications for neurodegenerative disorders.亨廷顿舞蹈病中两份照顾者生活质量问卷的心理测量学比较:对神经退行性疾病的启示
J Huntingtons Dis. 2013;2(3):315-22. doi: 10.3233/JHD-130065.
8
Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.亨廷顿舞蹈症患者及护理者群体调查揭示最具影响的症状和治疗需求
J Huntingtons Dis. 2016 Dec 15;5(4):395-403. doi: 10.3233/JHD-160228.
9
Assessment of Caregiver Burden in Huntington's Disease.亨廷顿舞蹈症患者照料者负担的评估
J Huntingtons Dis. 2019;8(1):111-114. doi: 10.3233/JHD-180326.
10
Quality of Care for Huntington's Disease in the United States: Findings from a National Survey of Patients and Caregivers.美国亨廷顿舞蹈症的护理质量:一项针对患者及护理人员的全国性调查结果
J Huntingtons Dis. 2019;8(4):509-519. doi: 10.3233/JHD-190380.

引用本文的文献

1
Variation in the reported prevalence of Huntington's disease: a systematic review and guide to interpretation.亨廷顿舞蹈症报告患病率的差异:系统评价与解读指南
J Neurol. 2025 Jul 24;272(8):534. doi: 10.1007/s00415-025-13255-1.
2
Validation of the Korean Version of the Huntington's Disease Quality of Life Battery for Carers.韩国版亨廷顿舞蹈病患者照料者生活质量量表的验证
J Mov Disord. 2025 Apr;18(2):160-164. doi: 10.14802/jmd.24217. Epub 2024 Dec 30.
3
Health state utility estimates for value assessments of novel treatments in Huntington's disease: a systematic literature review.

本文引用的文献

1
The Impact of Upcoming Treatments in Huntington's Disease: Resource Capacity Limitations and Access to Care Implications.即将到来的亨廷顿病治疗的影响:资源能力限制和获得医疗的影响。
J Huntingtons Dis. 2021;10(2):303-311. doi: 10.3233/JHD-200462.
2
Shifts in office and virtual primary care during the early COVID-19 pandemic in Ontario, Canada.加拿大安大略省在2019冠状病毒病疫情早期期间门诊和虚拟初级保健的转变。
CMAJ. 2021 Feb 8;193(6):E200-E210. doi: 10.1503/cmaj.202303.
3
Quality of Care for Huntington's Disease in the United States: Findings from a National Survey of Patients and Caregivers.
用于亨廷顿病新型治疗方法价值评估的健康状态效用估计值:系统文献回顾。
Health Qual Life Outcomes. 2024 Apr 16;22(1):33. doi: 10.1186/s12955-024-02242-1.
4
Canadian healthcare capacity gaps for disease-modifying treatment in Huntington's disease: a survey of current practice and modelling of future needs.加拿大亨廷顿舞蹈病疾病修正治疗的医疗能力差距:对当前实践的调查和未来需求的建模。
BMJ Open. 2022 Jun 1;12(6):e062740. doi: 10.1136/bmjopen-2022-062740.
美国亨廷顿舞蹈症的护理质量:一项针对患者及护理人员的全国性调查结果
J Huntingtons Dis. 2019;8(4):509-519. doi: 10.3233/JHD-190380.
4
Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN).亨廷顿病的健康状态效用值(QALY 权重):来自欧洲亨廷顿病网络(EHDN)的数据分析。
Eur J Health Econ. 2019 Dec;20(9):1335-1347. doi: 10.1007/s10198-019-01092-9. Epub 2019 Aug 13.
5
Anosognosia Is Associated With Greater Caregiver Burden and Poorer Executive Function in Huntington Disease.认知障碍与亨廷顿病患者的照料负担增加和执行功能下降有关。
J Geriatr Psychiatry Neurol. 2020 Jan;33(1):52-58. doi: 10.1177/0891988719856697. Epub 2019 Jun 18.
6
Meaningful and Measurable Health Domains in Huntington's Disease: Large-Scale Validation of the Huntington's Disease Health-Related Quality of Life Questionnaire Across Severity Stages.亨廷顿病中有意义和可衡量的健康领域:在严重程度阶段对亨廷顿病健康相关生活质量问卷进行大规模验证。
Value Health. 2019 Jun;22(6):712-720. doi: 10.1016/j.jval.2019.01.016.
7
Ancillary Service Utilization and Impact in Huntington's Disease.亨廷顿舞蹈症的辅助服务利用情况及其影响
J Huntingtons Dis. 2019;8(3):301-310. doi: 10.3233/JHD-190349.
8
The prevalence and the burden of pain in patients with Huntington disease: a systematic review and meta-analysis.亨廷顿病患者疼痛的患病率和负担:系统评价和荟萃分析。
Pain. 2019 Apr;160(4):773-783. doi: 10.1097/j.pain.0000000000001472.
9
Development of the Integrated Parkinson's Care Network (IPCN): using co-design to plan collaborative care for people with Parkinson's disease.一体化帕金森病护理网络(IPCN)的发展:运用共同设计为帕金森病患者规划协作式护理。
Qual Life Res. 2019 May;28(5):1355-1364. doi: 10.1007/s11136-018-2092-0. Epub 2019 Jan 2.
10
Huntington's Disease: Prevalence and Psychological Indicators of Pain.亨廷顿舞蹈症:疼痛的患病率及心理指标
Mov Disord Clin Pract. 2016 Jun 6;4(2):198-204. doi: 10.1002/mdc3.12376. eCollection 2017 Mar-Apr.